MKI67 and breast carcinoma: Previous studies have suggested that higher levels of Ki-67 in patients with early-stage breast cancer are associated with a worse prognosis and can accurately determine whether breast cancer has metastasised, thus providing a valuable reference for clinical diagnosis and treatment [26, 27].